Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A wearable biomechanical system for medical evaluation of soft tissue disorders.

Science advances·2026
Same author

3D Passive Cavitation Mapping (3D-PCM) with a Large-aperture Planar Array.

bioRxiv : the preprint server for biology·2026
Same author

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Skin-interfaced microfluidic capsule and portable lab-on-a-disc platform for sweat-based monitoring of prenatal nutrient balance.

Nature biomedical engineering·2026
Same author

Shape-conformal porous frameworks for full coverage of neural organoids and high-resolution electrophysiology.

Nature biomedical engineering·2026
Same author

Multiscale 3D microfluidic platform for intraorganoid delivery.

Research square·2026

Related Experiment Video

Updated: Jun 16, 2026

Fabrication of Carbon-Based Ionic Electromechanically Active Soft Actuators
14:42

Fabrication of Carbon-Based Ionic Electromechanically Active Soft Actuators

Published on: April 25, 2020

8.5K

Modeling programmable drug delivery in bioelectronics with electrochemical actuation.

Raudel Avila1, Chenhang Li1, Yeguang Xue1

  • 1Department of Mechanical Engineering, Northwestern University, Evanston, IL 60208.

Proceedings of the National Academy of Sciences of the United States of America
|April 10, 2021
PubMed
Summary

This study introduces a new analytical model for electrochemical drug delivery systems. The model accurately predicts flow rate and delivery time by including microfluidic resistance and membrane stiffness, crucial for neuroscience applications.

Keywords:
analytical modeldrug deliveryelectrochemical actuationflexible membranemechanics

More Related Videos

Bioinspired Soft Robot with Incorporated Microelectrodes
08:24

Bioinspired Soft Robot with Incorporated Microelectrodes

Published on: February 28, 2020

9.1K
Bridging the Bio-Electronic Interface with Biofabrication
16:38

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

17.0K

Related Experiment Videos

Last Updated: Jun 16, 2026

Fabrication of Carbon-Based Ionic Electromechanically Active Soft Actuators
14:42

Fabrication of Carbon-Based Ionic Electromechanically Active Soft Actuators

Published on: April 25, 2020

8.5K
Bioinspired Soft Robot with Incorporated Microelectrodes
08:24

Bioinspired Soft Robot with Incorporated Microelectrodes

Published on: February 28, 2020

9.1K
Bridging the Bio-Electronic Interface with Biofabrication
16:38

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

17.0K

Area of Science:

  • Biomedical Engineering
  • Neuroscience
  • Materials Science

Background:

  • Electrochemical actuation enables programmable drug delivery systems for localized administration.
  • Current models for flow rate and delivery time in these systems neglect microfluidic resistance and membrane stiffness.

Purpose of the Study:

  • To develop an analytical model for electrochemical drug delivery systems that incorporates microfluidic resistance and membrane stiffness.
  • To provide a scalable understanding of how key variables influence the physics of the drug delivery process.

Main Methods:

  • An analytical model was established, considering parameters such as initial pressure, volume, microfluidic resistance, membrane flexibility, current, and temperature.
  • The model bypasses the need for numerical simulations, enabling faster system optimization.
  • The model's predictions were validated against numerical results and experimental data.

Main Results:

  • The developed analytical model accurately predicts maximum flow rate and delivery time.
  • The model demonstrates that the delivery process is governed by three key nondimensional parameters.
  • Results from the analytical model show strong agreement with numerical simulations and experimental findings.

Conclusions:

  • The proposed analytical model offers a more comprehensive understanding of electrochemical drug delivery systems.
  • This model facilitates faster optimization for in vivo experiments in neuroscience and other biomedical fields.
  • The findings are relevant for emerging clinical applications requiring precise, programmable drug delivery.